Biology of Human Herpesvirus 8: Novel Functions and Virus–Host Interactions Implicated in Viral Pathogenesis and Replication

Feb 18, 2017 by in ONCOLOGY Comments Off on Biology of Human Herpesvirus 8: Novel Functions and Virus–Host Interactions Implicated in Viral Pathogenesis and Replication

Fig. 1 ER-localized interactions and activities of vIL-6 in latently infected PEL cells. In the context of PEL latency, vIL-6 is expressed at low but functional levels and is largely sequestered…

read more

of Virus Infection and Human Cancer

Feb 18, 2017 by in ONCOLOGY Comments Off on of Virus Infection and Human Cancer

Virus Cancer sites with sufficient evidence Cancer sites with limited evidence Epstein–Barr virus (EBV) Nasopharyngeal carcinoma, Burkitt’s lymphoma, immune suppression-related non-Hodgkin lymphoma, extranodal NK/T cell lymphoma (nasal type), Hodgkin’s lymphoma…

read more

Oncogenic Role of Hepatitis C Virus

Feb 18, 2017 by in ONCOLOGY Comments Off on Oncogenic Role of Hepatitis C Virus

Fig. 1 The structure of hepatitis C virus genome. The HCV genome RNA encodes a polyprotein of 3,010 a.a., which is processed into structural and non-structural proteins by the cellular or…

read more

of Hepatitis B Virus Infection and Liver Cancer

Feb 18, 2017 by in ONCOLOGY Comments Off on of Hepatitis B Virus Infection and Liver Cancer

Risk factors High risk/low risk References Viral factors    1. HBsAg Positive/negative = 66/1 Beasley et al. (1981) 2. HBeAg in HBsAg-positive persons Positive/negative = 60/10 Yang et al. (2002) 3. HBV DNA level…

read more

of HPV Infection and Related Cancer Through Vaccination

Feb 18, 2017 by in ONCOLOGY Comments Off on of HPV Infection and Related Cancer Through Vaccination

Type Advantage Disadvantage Developmental stage References Live vector-based Highly immunogenic customizable Vector-specific neutralizing antibodies or pre-existing vector-specific immunity, safety concerns, flu-like adverse effects ADXS11-001 in phase II Trial Maciag et…

read more

Treatment and Cancer Control

Feb 18, 2017 by in ONCOLOGY Comments Off on Treatment and Cancer Control

Virus a Cancer type b Antiviral therapy c   HBV HCC Interferons (Interferon-α and pegylated interferon-α2a)   Nucleos(t)ide analogues (Lamivudine, adefovir, entecavir, telbivudine, and tenofovir) HCV HCC Peglyated interferon plus ribavirin   …

read more

Role of Human Papillomaviruses in Oncogenesis

Feb 18, 2017 by in ONCOLOGY Comments Off on Role of Human Papillomaviruses in Oncogenesis

Fig. 1 Differentiation-dependent HPV Life Cycle. The HPV life cycle is intimately associated with the differentiation program of epithelial cells. HPV infects actively dividing cells in basal layer of the epithelium…

read more

of Hepatitis C Virus Infection and Liver Cancer

Feb 18, 2017 by in ONCOLOGY Comments Off on of Hepatitis C Virus Infection and Liver Cancer

Fig. 1 Natural history of HCV infection. Adapted from Alter et al. (1995) HCV belongs to the genus Hepacivirus in the Flaviviridae family (Forns and Bukh 1999). It has a single-stranded…

read more
Get Clinical Tree app for offline access